arfy, dr. f, and other medical professionals, as a drug rep myself i feel i must chime in. Dr. F's concerns w/ hormone levels are very insightful. The fact that the drug should not be handled by women who are pregnant, and if i remember correctly, those who intend on being pregnant, should be a red flag. A problem i have as a rep is that a drug originally studied for bph, turns out to grow hair on mpb individuals. And because merck had the resources to do the studies to market propecia as a hairloss drug, the fda has not linked the relationship between bph and hairloss. In my opinion, any drug for bph should contain the same warning for pregnant women, or those who intend to become pregnant